(Q43211411)

English

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity

scientific article published on 22 December 2009

Statements

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity (English)
Christine M Chresta
Susan E Critchlow
Phillippa Dudley
Marc Hummersone
Richard Jenkins
Graeme C M Smith
Sylvie Guichard

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit